| Pharmaceutical Information |
| Drug Name |
Phosphonatoformate |
| Drug ID |
BADD_D01767 |
| Description |
An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpes viruses and HIV. |
| Indications and Usage |
For the treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS) and for treatment of acyclovir-resistant mucocutaneous HSV infections in immunocompromised patients. |
| Marketing Status |
approved |
| ATC Code |
J05AD01 |
| DrugBank ID |
DB00529
|
| KEGG ID |
D00579; D02267
|
| MeSH ID |
D017245
|
| PubChem ID |
3414
|
| TTD Drug ID |
D0OT0O
|
| NDC Product Code |
Not Available |
| UNII |
364P9RVW4X
|
| Synonyms |
Foscarnet | Phosphonoformic Acid | Foscarnet Trisodium Salt | Foscarnet Calcium (2:3) Salt | Foscarnet Disodium Salt | Foscarnet Magnesium (2:3) Salt | Trisodium Phosphonoformate | Phosphonoformate | Foscarnet Sodium | Foscarnet Trilithium Salt | Foscarnet Tripotassium Salt | Foscarnet Sodium Hexahydrate | Foscavir | Foscarnet Barium (2:3) Salt | Foscarnet Manganese (2+) (2:3) Salt |
|
| Chemical Information |
| Molecular Formula |
CO5P-3 |
| CAS Registry Number |
4428-95-9 |
| SMILES |
C(=O)([O-])P(=O)([O-])[O-] |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
